Similar Articles
511 Surgery for hepatocellular carcinoma with tumor thrombosis in inferior vena cava: A case report
512 Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma
513 Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?
514 Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures
515 Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
516 Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma
517 Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy
518 Anatomic resection improved the long-term outcome of hepatocellular carcinoma patients with microvascular invasion: A prospective cohort study
519 Critical biomarkers of hepatocellular carcinoma in body fluids and gut microbiota
520 Recombinant protein Schistosoma japonicum-derived molecule attenuates dextran sulfate sodium-induced colitis by inhibiting miRNA-217-5p to alleviate apoptosis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA